Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 3rd:Halozyme Therapeutics (HALO) : This biopharmaceutical company which is focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment, has a Zacks Rank #1 (Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.5% over the last 60 days.Halozyme Therapeutics' shares gained 36.2% ov ...